Meta AnalysisID 601

鸦片消耗与人类癌症:系统评价与Meta分析

CRD42021236030

Does opium consumption [smoked or ingested] increase the risk of either incidence or mortality of cancer in adults?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
601
Evidence Id
9159
Core Evidence Id
9159
Source Meta Analysis Id
578
Herb2 Meta Analysis Id
HBMA000578
Crd Id
CRD42021236030
Title
Opium consumption and cancer in humans: a systematic review and meta-analysis
Review Question
Does opium consumption [smoked or ingested] increase the risk of either incidence or mortality of cancer in adults?
Study Type Included
Cohort and case-control studies.
Condition Being Studied
We will include as an outcome five different cancers types, namely, cancers in the larynx, lung, bladder, oesophagus and stomach. The outcomes of main interest are cancers of larynx, lung, and bladder, which are not the subject of any known in-progress meta-analyses; however, because there are new cohort studies examining cancers of oesophagus and stomach (in addition to the sites of primary interest), we will also incorporate analyses of these cancer outcomes.
Participant
The systematic review and meta-analysis will include studies of humans exposed environmentally to minimally processed opium via consumption. These studies will be of either (i) populations (cohorts) whose opium consumption patterns are examined and cancer experience followed prospectively, with cancer rates compared among exposed and unexposed and by exposure category; or (ii) case-control studies of populations (e.g., patients) diagnosed with or deceased from cancer for whom previous exposure to opium consumption has been estimated and compared with the opium exposure of persons who did not have cancer. The evaluation will include only populations exposed to minimally processed forms of opium (e.g., raw opium, opium dross, opium sap). Populations exposed only to other opiates (e.g., heroin, codeine) or opioids (e.g. fentanyl) will not be included.
Animal
Human Disease Modelled
Intervention
Individual or group levels (intensity and duration) of opium smoked or ingested, measured either through questionnaire interviewing or using biological metabolites, are the main exposure of interest. Variables may be categorized as “never” vs “ever” exposed to opium consumption, or by levels of duration or intensity of opium consumption, or to cumulative opium (e.g., nokhod-years).
Comparator Control
In cohort studies the comparison group will be represented by the individual non-exposed to opium consumption at the baseline of study; and control group in case-control studies are those patients without cancer diagnosis or cancer death.
Main Outcome
Diagnosis and death of any malignant neoplasm in humans. Measures of effect Relative risks, odds ratios
Outcome Measure
Additional Outcome
None Measures of effect Not applicable
Study Method
Epidemiologic, Meta-analysis, Systematic review
Keyword
Humans; Neoplasms; Opium
Contact
Organisational Affiliation
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Review Stage
First Submission Date
Registration Date
Anticipated Start Date
Anticipated Completion Date
Title Cn
鸦片消耗与人类癌症:系统评价与Meta分析
Title En
Opium consumption and cancer in humans: a systematic review and meta-analysis
Bilingual Status
complete